Cargando…
Factors Associated With Poor Response To Clozapine In Schizophrenia: A Study From Northern India
BACKGROUND: Clozapine is considered the antipsychotic of choice for patients with Treatment-Resistant Schizophrenia (TRS). Despite its proven efficacy in TRS, around 40–70% of patients have a poor response to clozapine. Limited numbers of studies have assessed the predictors of clozapine non-respons...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer - Medknow
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9129325/ http://dx.doi.org/10.4103/0019-5545.341604 |